Eli Lilly and Company · 19 hours ago
In Vivo Sr. Biologist - Obesity Research
Boston, MA
Full-time
Onsite
Mid, Senior Level
$71K/yr - $187K/yr
2+ years expEli Lilly and Company is a global healthcare leader headquartered in Indianapolis, Indiana, focused on discovering and bringing life-changing medicines to those in need. They are seeking a skilled individual to join their Obesity research group, where the successful candidate will leverage their in vivo background to support drug discovery efforts and pipeline projects related to anti-obesity therapeutics.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Plan and independently carry out experiments in rodent models to support preclinical characterization and evaluation of targets/pathways that regulate energy metabolism
Proficient at rodent handling, dosing, and necropsy/tissue collection
Perform molecular and biochemical assessments on ex vivo samples in collaboration with colleagues in other departments (qPCR, Western blot, ELISA, etc…)
Function independently, work within a team-oriented lab environment, and work within cross-functional project teams
This role is a full-time position that requires some weekend work
Requirement for accurate record keeping, independent data analysis, and reporting of data in written and oral formats. Will perform work in full compliance with Lilly Research Policies and complete all required training activities in the timeframe specified
Qualification
Required
B.S. or M.S. in biology, pharmacology, or a closely related field
2+ years of demonstrated hands-on expertise performing small animal studies
Plan and independently carry out experiments in rodent models to support preclinical characterization and evaluation of targets/pathways that regulate energy metabolism
Proficient at rodent handling, dosing, and necropsy/tissue collection
Perform molecular and biochemical assessments on ex vivo samples in collaboration with colleagues in other departments (qPCR, Western blot, ELISA, etc…)
Function independently, work within a team-oriented lab environment, and work within cross-functional project teams
Requirement for accurate record keeping, independent data analysis, and reporting of data in written and oral formats
Will perform work in full compliance with Lilly Research Policies and complete all required training activities in the timeframe specified
Preferred
Experience with common in vivo metabolic assessments (glucose tolerance tests, exercise capacity, etc…)
Demonstrated hands-on expertise performing small animal obesity studies
Familiarity with ex vivo models of adipose tissue and hepatocytes
Experience with rodent survival surgeries
Ability to prioritize activities across multiple projects independently and effectively
Strong communication skills and experience presenting data in a team environment
Benefits
Company bonus
401(k)
Pension
Vacation benefits
Medical, dental, vision and prescription drug benefits
Flexible benefits (e.g., healthcare and/or dependent day care flexible spending accounts)
Life insurance and death benefits
Certain time off and leave of absence benefits
Well-being benefits (e.g., employee assistance program, fitness benefits, and employee clubs and activities)
Company
Eli Lilly and Company
We're a medicine company turning science into healing to make life better for people around the world.
10001+ employees
H1B Sponsorship
Eli Lilly and Company has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (514)
2024 (236)
2023 (167)
2022 (133)
2021 (57)
2020 (52)
Funding
Current Stage
Public CompanyTotal Funding
$6.5M2024-02-12Post Ipo Debt· $6.5M
1978-01-13IPO
Leadership Team
David Ricks
Chair, CEO
Lucas Montarce
Executive Vice President and Chief Financial Officer
Recent News
The Motley Fool
2026-01-25
2026-01-24
2026-01-23
Company data provided by crunchbase